ALICIA ROTHCHILD: Open Payments
NPI 1972356640 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 43 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,771 · 2025 $1,362
Food & beverage: $1,263Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $331 |
| BeOne Medicines USA, Inc. | 1 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Celgene Corporation | 2 | $94 |
| Merck Sharp & Dohme LLC | 3 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| Incyte Corporation | 2 | $40 |
| PFIZER INC. | 2 | $38 |
Products named: TALVEY, TEVIMBRA, DARZALEX, REBLOZYL, KEYTRUDA, KISQALI, OPDIVO, CALQUENCE.
Industry payments across IN — which companies pay providers there.
